Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1330780979
Thu, 18.09.2025
Curatis Holding AG
Curatis Holding AG
/ Key word(s): Miscellaneous
FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
18.09.2025 / 07:00 CET/CEST
MEDIA RELEASE
Liestal, Switzerland, 18. September 2025: Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting whi [ … ]
Mon, 15.09.2025
Curatis Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Liestal, Switzerland, 15 September 2025: Curatis Holding AG (SIX:CURN) reports revenues of CHF 5.2m for H1 2025, a like for like yoy growth of 14% vs 6 months of revenues of Curatis AG in 2024. In addition, Curatis was able to sign a significant partnership with Phoenix Labs, Ireland, adding 4 products tha [ … ]
Fri, 05.09.2025
Curatis Holding AG
Curatis Holding AG
/ Key word(s): Agreement/Incoming Orders
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
05.09.2025 / 07:00 CET/CEST
MEDIA RELEASE
Liestal, Switzerland, 5 September 2025: Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contrac [ … ]
Thu, 31.07.2025
Curatis Holding AG
Curatis Holding AG
/ Key word(s): Legal Matter/Strategic Company Decision
FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
31.07.2025 / 06:00 CET/CEST
MEDIA RELEASE
Liestal, Switzerland– Curatis Holding AG (SIX: CURN) – July 31, 2025. The U.S. Food and Drug Administration (FDA) have agreed to a Type B m [ … ]
Sat, 24.05.2025
Curatis Holding AG
Curatis Holding AG
/ Key word(s): AGMEGM
Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
24.05.2025 / 11:31 CET/CEST
MEDIA RELEASE
Liestal, Switzerland, 23 May 2025: Curatis Holding AG (CURN.SW), a SIX Swiss Exchange listed specialty pharmaceutical and therapeutic drug devel [ … ]
Fri, 23.05.2025
Curatis Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Liestal, Switzerland, 23 May 2025: An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema (PTBE) in association w [ … ]
Thu, 27.03.2025
Curatis Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Liestal, Schweiz, 27. März 2025: Die Curatis Holding AG (SIX:CURN, "Curatis") weist für das Jahr 2024 einen Geschäftserlös von CHF 6.9m aus, wobei die Curatis AG hierin nur für 8 Monate berücksichtigt ist. Die Curatis AG konnte den Umsatz im Vertriebsgeschäft im gesamten Jahr 2024 im Vergleich zu 2023 um 3 [ … ]
Tue, 11.03.2025
Curatis Holding AG
Curatis Holding AG
/ Key word(s): Strategic Company Decision
Curatis Announces Formation of Distinguished Advisory Board
11.03.2025 / 07:00 CET/CEST
MEDIA RELEASE
Liestal, Switzerland, 11 March 2025: Curatis Holding (SIX:CURN) announces today the formation of an Advisory Board comprised of four internationally recognize [ … ]
